Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
26/07/202223h53Dow Jones NewsTeva Pharma ADRs Jump 17% On Pending Nationwide Agreement Over Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
26/07/202222h55Business WireTeva Reports Second Quarter 2022 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/07/202214h00GlobeNewswire Inc.Certara Appoints Rosemary Crane as New Independent Board MemberNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/202215h53PR Newswire (US)Teva Pharmaceuticals accredited Migraine Friendly Workplace StampNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202223h05Dow Jones NewsADRs End Lower; Teva Pharmaceutical, Banco Santander Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202218h39Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San Francisco -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202217h38Dow Jones NewsTeva Pharmaceutical, Abbvie's Allergan Settle Opioid Suit With San FranciscoNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/202216h30Business WireTeva Reaches Agreement With San Francisco to Settle Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202217h11Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid Case -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/202216h31Dow Jones NewsNew York Attorney General Seeks to Bring Teva Back Into Opioid CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
05/07/202214h56Dow Jones NewsAgilent: FDA Approves Teva's Content Uniformity Method Using TRS100 SystemNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/202214h34Business WireTeva Announces Appointment of New Global R&D and Chief Medical OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
29/06/202222h09Business WireTeva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022NYSE:TEVATeva Pharmaceutical Industries Ltd
26/06/202202h45Business WireTeva veröffentlicht vielversprechende Zwischenergebnisse der PEARL-Studie zur Wirksamkeit von AJOVY® (Fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
25/06/202218h16Business WireTeva annonce des résultats provisoires prometteurs de son étude PEARL concernant l’impact d’AJOVY® (frémanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/202218h54Business WireTeva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/202222h03Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202223h15Business WireTeva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent DisputeNYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202214h00Business WireNew Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Presented at 2022 American Headache Society Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/202213h45Business WireTeva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
08/06/202215h00Business WireDirect Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health ServicesNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202216h38Dow Jones NewsTeva Pharmaceutical Settles Opioid Suit With West VirginiaNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202215h36Business WireTeva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/05/202214h01Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:TEVATeva Pharmaceutical Industries Ltd
23/05/202214h00Business WireTeva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric Association Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
19/05/202213h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
18/05/202200h26Business WirePremière licence accordée au Royaume-Uni pour le biosimilaire ophtalmologique de Teva, Ongavia (ranibizumab)▼NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202221h02Business WireGroßbritannien erteilt als erstes Land eine Zulassung für das ophthalmologische Biosimilar Ongavia (Ranibizumab) von Teva▼NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202215h10Business WireUnited Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202214h00Business WireTeva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

Delayed Upgrade Clock